BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26492543)

  • 21. Mandibular Lytic Lesion in Familial Paraganglioma Syndrome Type I: A Clinical Conundrum.
    Sinha P; Yuen SN; Chernock RD; Haughey BH
    Ann Otol Rhinol Laryngol; 2017 Aug; 126(8):615-618. PubMed ID: 28670912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
    Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
    BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SDHB, SDHC, and SDHD mutation screen in sporadic and familial head and neck paragangliomas.
    Mhatre AN; Li Y; Feng L; Gasperin A; Lalwani AK
    Clin Genet; 2004 Nov; 66(5):461-6. PubMed ID: 15479192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positive Immunostaining for Succinate Dehydrogenase B (SDHB) in Paraganglioma Associated with Germline Mutation of SDHB, L157X and P236S.
    Sato H; Inomoto C
    Tokai J Exp Clin Med; 2020 Sep; 45(3):148-151. PubMed ID: 32901905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance and peculiarities of succinate dehydrogenase B and hypoxia inducible factor 1α expression in parasympathetic versus sympathetic paragangliomas.
    Bernardo-Castiñeira C; Sáenz-de-Santa-María I; Valdés N; Astudillo A; Balbín M; Pitiot AS; Jiménez-Fonseca P; Scola B; Tena I; Molina-Garrido MJ; Sevilla MA; Beristein E; Forga L; Villabona C; Oriola J; Halperin I; Suarez C; Chiara MD
    Head Neck; 2019 Jan; 41(1):79-91. PubMed ID: 30549360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
    Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIF-1α and HIF-2α correlate with migration and invasion in gastric cancer.
    Wang Y; Li Z; Zhang H; Jin H; Sun L; Dong H; Xu M; Zhao P; Zhang B; Wang J; Pan Y; Liu L
    Cancer Biol Ther; 2010 Aug; 10(4):376-82. PubMed ID: 20559021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simple and rapid characterization of novel large germline deletions in SDHB, SDHC and SDHD-related paraganglioma.
    Hoekstra AS; van den Ende B; Julià XP; van Breemen L; Scheurwater K; Tops CM; Malinoc A; Devilee P; Neumann HP; Bayley JP
    Clin Genet; 2017 Apr; 91(4):536-544. PubMed ID: 27485256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytoplasmic HIF-2α as tissue biomarker to identify metastatic sympathetic paraganglioma.
    Karakaya S; Gunnesson L; Elias E; Martos-Salvo P; Robledo M; Nilsson O; Wängberg B; Abel F; Påhlman S; Muth A; Mohlin S
    Sci Rep; 2023 Jul; 13(1):11588. PubMed ID: 37463949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship of erythropoietin overexpression with von Hippel-Lindau tumour suppressor gene mutations between hypoxia-inducible factor-1α and -2α in sporadic clear cell renal carcinoma.
    Gong K; Zhang N; Zhang K; Na Y
    Int J Mol Med; 2010 Dec; 26(6):907-12. PubMed ID: 21042786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characterization of novel germline deletions affecting SDHD and SDHC in pheochromocytoma and paraganglioma patients.
    Bayley JP; Weiss MM; Grimbergen A; van Brussel BT; Hes FJ; Jansen JC; Verhoef S; Devilee P; Corssmit EP; Vriends AH
    Endocr Relat Cancer; 2009 Sep; 16(3):929-37. PubMed ID: 19546167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetics and the clinical approach to paragangliomas.
    Schulte KM; Talat N; Galata G; Aylwin S; Izatt L; Eisenhofer G; Barthel A; Bornstein SR
    Horm Metab Res; 2014 Dec; 46(13):964-73. PubMed ID: 25014332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Somatic HIF2α Mutation-Induced Multiple and Recurrent Pheochromocytoma/Paraganglioma with Polycythemia: Clinical Study with Literature Review.
    Liu Q; Wang Y; Tong D; Liu G; Yuan W; Zhang J; Ye J; Zhang Y; Yuan G; Feng Q; Zhang D; Jiang J
    Endocr Pathol; 2017 Mar; 28(1):75-82. PubMed ID: 28116635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Full Phenotype of Paraganglioma Linked to a Germline SDHB Mosaic Mutation.
    Cardot-Bauters C; Carnaille B; Aubert S; Crépin M; Boury S; Burnichon N; Pigny P
    J Clin Endocrinol Metab; 2019 Aug; 104(8):3362-3366. PubMed ID: 31046099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites?
    Grouzmann E; Tschopp O; Triponez F; Matter M; Bilz S; Brändle M; Drechser T; Sigrist S; Zulewski H; Henzen C; Fischli S; Abid K
    PLoS One; 2015; 10(5):e0125426. PubMed ID: 25946206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancer.
    Winter SC; Shah KA; Han C; Campo L; Turley H; Leek R; Corbridge RJ; Cox GJ; Harris AL
    Cancer; 2006 Aug; 107(4):757-66. PubMed ID: 16826581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Roles of hypoxia-inducible factor-1alpha (HIF-1alpha) versus HIF-2alpha in the survival of hepatocellular tumor spheroids.
    Menrad H; Werno C; Schmid T; Copanaki E; Deller T; Dehne N; Brüne B
    Hepatology; 2010 Jun; 51(6):2183-92. PubMed ID: 20513003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Kaposi's Sarcoma-Associated Herpesvirus ORF34 Protein Interacts and Stabilizes HIF-2α via Binding to the HIF-2α bHLH and PAS Domains.
    Haque M; Kousoulas KG
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes.
    Gill AJ; Benn DE; Chou A; Clarkson A; Muljono A; Meyer-Rochow GY; Richardson AL; Sidhu SB; Robinson BG; Clifton-Bligh RJ
    Hum Pathol; 2010 Jun; 41(6):805-14. PubMed ID: 20236688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel SDHB and TMEM127 Mutations in Patients with Pheochromocytoma/Paraganglioma Syndrome.
    Patócs A; Lendvai NK; Butz H; Liko I; Sapi Z; Szucs N; Toth G; Grolmusz VK; Igaz P; Toth M; Rácz K
    Pathol Oncol Res; 2016 Oct; 22(4):673-9. PubMed ID: 26960314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.